Renal cell carcinoma
10.1016/s0140-6736(09)60229-4 · 2009
Kidney cancer pathology in the new context of targeted therapy
10.1159/000315543 · 2011
Elucidation of a universal size-control mechanism in Drosophila and mammals
10.1016/j.cell.2007.07.019 · 2007
The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
10.1016/j.ccr.2008.02.011 · 2008
Expression of Yes-associated protein in common solid tumors
10.1016/j.humpath.2008.04.012 · 2008
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
10.1002/cncr.24495 · 2009
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
10.1101/gad.1824509 · 2009
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression
1996
Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures
2000
Characterization of primary renal carcinoma cultures
10.1159/000107956 · 2007
Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification
10.1128/aem.58.8.2606-2615.1992 · 1992
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers
10.1158/0008-5472.can-06-3281 · 2007
A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background
10.1016/j.jim.2006.07.027 · 2007
A novel signaling pathway impact analysis
10.1093/bioinformatics/btn577 · 2009
Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method
10.1006/meth.2001.1262 · 2001
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
10.4161/cbt.12.7.16475 · 2011
Cancer genome landscapes
10.1126/science.1235122 · 2013
The predictive capacity of personal genome sequencing
10.1126/scitranslmed.3003380 · 2012
Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma
10.1186/1471-2407-11-523 · 2011
High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma
10.1002/path.2239 · 2007
Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma
10.1158/0008-5472.can-12-0656 · 2012
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
10.1038/ng.1014 · 2012
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
10.1038/nature08672 · 2010
Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma
10.1073/pnas.0902031106 · 2009
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
10.1083/jcb.201009069 · 2011
The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ
10.1093/hmg/dds408 · 2012
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
10.1073/pnas.1212021109 · 2012
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues
10.1136/mp.54.2.57 · 2001
Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells
10.1093/carcin/bgn019 · 2008
Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro
10.5414/cpp51047 · 2013
The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival
10.1016/j.juro.2009.07.015 · 2009
Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?
10.1016/j.lfs.2012.07.034 · 2012
Endothelin-1 promotes cell survival in renal cell carcinoma through the ETA receptor
10.1016/j.canlet.2006.02.007 · 2007
Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma
10.1002/cncr.20222 · 2004
Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma
10.1038/bjc.2011.515 · 2012
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer
10.1111/j.1476-5381.2011.01786.x · 2013
Specific expression of human endothelin-2 (ET-2) gene in a renal adenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization
10.1016/0014-5793(90)81348-r · 1990
Expression of endothelin 2 and localized clear cell renal cell carcinoma
10.1016/j.humpath.2011.07.011 · 2012
A role for endothelin-2 and its receptors in breast tumor cell invasion
10.1158/0008-5472.can-03-1069 · 2004
Expression of endothelins and their receptors promotes an invasive phenotype of breast tumor cells but is insufficient to induce invasion in benign cells
10.1089/dna.2005.24.766 · 2005
